| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |